CH668912A5 - DISINFECTANT COMPOSITION FOR HUMAN OR VETERINARY USE. - Google Patents

DISINFECTANT COMPOSITION FOR HUMAN OR VETERINARY USE. Download PDF

Info

Publication number
CH668912A5
CH668912A5 CH495386A CH495386A CH668912A5 CH 668912 A5 CH668912 A5 CH 668912A5 CH 495386 A CH495386 A CH 495386A CH 495386 A CH495386 A CH 495386A CH 668912 A5 CH668912 A5 CH 668912A5
Authority
CH
Switzerland
Prior art keywords
emulsion
anesthetic agent
composition
water
hydrogen peroxide
Prior art date
Application number
CH495386A
Other languages
French (fr)
Inventor
Paul Dr Med Herzog
Original Assignee
Paul Dr Med Herzog
Karin Herzog Thomander
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paul Dr Med Herzog, Karin Herzog Thomander filed Critical Paul Dr Med Herzog
Priority to CH495386A priority Critical patent/CH668912A5/en
Priority to DE19873741561 priority patent/DE3741561A1/en
Priority to FR8717235A priority patent/FR2608048A1/en
Priority to GB08728875A priority patent/GB2198642A/en
Publication of CH668912A5 publication Critical patent/CH668912A5/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/40Peroxides

Description

668912 668912

2 2

Claims (5)

REVENDICATIONS 1. Composition désinfectante, à usage humain ou vétérinaire, à base d'émulsion aqueuse de peroxyde d'hydrogène, caractérisée en ce qu'elle contient un agent anesthésique local, n'affectant pas la stabilité de l'émulsion.1. Disinfectant composition, for human or veterinary use, based on an aqueous emulsion of hydrogen peroxide, characterized in that it contains a local anesthetic agent, which does not affect the stability of the emulsion. 2. Composition selon la revendication 1, caractérisée en ce que l'agent anesthésique est un agent d'injection, d'infiltration ou de surface.2. Composition according to claim 1, characterized in that the anesthetic agent is an injection, infiltration or surface agent. 3. Composition selon la revendication 1 ou 2, caractérisée en ce que l'agent anesthésique est choisi parmi la classe des esters de l'acide benzoïque ou paraaminobenzoïque, les amides, notamment les amides d'acides aromatiques, les anilides, les uréthannes, les cétones et les éthers, notamment les cétones et les éthers alkylaroma-tiques.3. Composition according to claim 1 or 2, characterized in that the anesthetic agent is chosen from the class of benzoic or paraaminobenzoic acid esters, amides, in particular aromatic acid amides, anilides, urethanes, ketones and ethers, in particular ketones and alkylaromatic ethers. 4. Composition selon l'une des revendications 1 à 3, caractérisée en ce que l'agent anesthésique est choisi parmi la cocaïne, la pro-caïne, la cinchocaïne, la lidocaïne, le diperodon, la dyclonine, la pra-mocaïne ou certains de leurs sels hydrosolubles, notamment leurs chlorhydrates.4. Composition according to one of claims 1 to 3, characterized in that the anesthetic agent is chosen from cocaine, pro-caine, cinchocaine, lidocaine, diperodon, dyclonine, pra-mocaine or certain of their water-soluble salts, in particular their hydrochlorides. 5. Composition selon l'une des revendications 1 à 4, caractérisée en ce qu'elle contient l'agent anesthésique à raison d'environ 0,5 à environ 25% en poids.5. Composition according to one of claims 1 to 4, characterized in that it contains the anesthetic agent in an amount of approximately 0.5 to approximately 25% by weight. DESCRIPTIONDESCRIPTION L'invention a pour objet une composition désinfectante, à usage humain ou vétérinaire, à base d'émulsion aqueuse de peroxyde d'hydrogène. Elle est essentiellement destinée à un usage externe, notamment au traitement de plaies diverses ou d'affections de la peau.The subject of the invention is a disinfectant composition, for human or veterinary use, based on an aqueous emulsion of hydrogen peroxide. It is essentially intended for external use, in particular for the treatment of various wounds or skin conditions. Lors du traitement de plaies ou de certaines affections de la peau provoquant des blessures ouvertes, ou lors de brûlures telles des brûlures au second ou au troisième degré, on a nécessairement recours à l'emploi de désinfectants. De nombreux produits sont à ce jour à disposition des médecins, tels les dérivés de mercure, les composés organochlorés comme l'hexachlorophène, les solutions ou émulsions aqueuses de peroxyde d'hydrogène par exemple.When treating wounds or certain skin conditions causing open wounds, or during burns such as second or third degree burns, it is necessary to resort to the use of disinfectants. Many products are currently available to doctors, such as mercury derivatives, organochlorine compounds such as hexachlorophene, aqueous solutions or emulsions of hydrogen peroxide for example. Les solutions et émulsions aqueuses de peroxyde d'hydrogène, en particulier certaines émulsions du type huile-dans-eau, sont très appréciées pour la désinfection des brûlures graves, étant donné l'absence de composés actifs toxiques. Grâce à leur teneur élevée en oxygène actif, de telles émulsions favorisent la reconstruction des tissus détruits, accélérant ainsi la guérison des patients. On a cependant observé, sans pour autant trouver d'explications satisfaisantes à ce phénomène, que les douleurs caractéristiques des brûlures réapparaissent sensiblement plus tôt que lors du traitement avec d'autres . désinfectants. L'atténuation de telles douleurs s'effectue le plus généralement par voie interne (injections), au moyen d'agents anesthési-ques appropriés, un traitement externe local étant exclu, les conditions de stérilité ne pouvant pas être respectées.Aqueous solutions and emulsions of hydrogen peroxide, in particular certain emulsions of the oil-in-water type, are very popular for the disinfection of serious burns, given the absence of toxic active compounds. Thanks to their high content of active oxygen, such emulsions promote the reconstruction of destroyed tissues, thus accelerating the recovery of patients. However, it has been observed, without however finding a satisfactory explanation for this phenomenon, that the pain characteristic of burns reappears significantly earlier than during treatment with other . disinfectants. The alleviation of such pain is most generally carried out internally (injections), by means of appropriate anesthetic agents, local external treatment being excluded, the conditions of sterility not being able to be respected. La présente invention permet de surmonter avantageusement ces inconvénients en proposant une composition désinfectante, à usage humain ou vétérinaire, à base d'émulsion aqueuse de peroxyde d'hydrogène, caractérisée en ce qu'elle contient un agent anesthésique local n'affectant pas la stabilité de l'émulsion.The present invention makes it possible to overcome these drawbacks advantageously by proposing a disinfectant composition, for human or veterinary use, based on an aqueous emulsion of hydrogen peroxide, characterized in that it contains a local anesthetic agent which does not affect the stability emulsion. Selon l'invention, l'émulsion peut être une émulsion du type huile-dans-eau ou du type eau-dans-huile. Une émulsion huile-dans-eau stable, particulièrement bien adaptée à la préparation de la composition de l'invention est décrite dans le brevet US 3.954.974.According to the invention, the emulsion can be an emulsion of the oil-in-water type or of the water-in-oil type. A stable oil-in-water emulsion, particularly well suited to the preparation of the composition of the invention is described in US Pat. No. 3,954,974. Selon l'invention, l'agent anesthésique local est avantageusement choisi dans la classe des composés suivants: les esters de l'acide benzoïque ou paraaminobenzoïque, les amides, notamment les amides d'acides aromatiques, les anilides, les uréthannes, les cétones et les éthers, notamment les cétones et les éthers alkylaromatiques (voir à ce propos «Arbeitstechniken der pharmazeutischen Industrie», vol. 4, pp. 217 et suivantes, Georg Thieme Verlag, 1982).According to the invention, the local anesthetic agent is advantageously chosen from the class of the following compounds: esters of benzoic or para-aminobenzoic acid, amides, in particular aromatic acid amides, anilides, urethanes, ketones and ethers, in particular ketones and alkylaromatic ethers (see on this subject "Arbeitstechniken der pharmazeutischen Industrie", vol. 4, pp. 217 et seq., Georg Thieme Verlag, 1982). Un tel agent anesthésique peut être aussi bien un agent d'injection, d'infiltration ou de surface dès lors qu'il se prête à la préparation de la composition selon l'invention et développe son effet une fois au contact des tissus. On choisira de préférence ledit agent anesthésique parmi la cocaïne, la procaïne, la cinchocaïne, la lidocaïne, le diperodon, la dyclonine, la pramocaïne ou certains de leurs sels hydrosolubles, notamment leurs chlorhydrates. A titre de chlorhydrates, on peut notamment citer les chlorhydrates de cocaïne, de procaïne, de tétracaïne ou de lidocaïne (Xylocaine marque enregistrée), ce dernier étant particulièrement apprécié.Such an anesthetic agent can equally well be an injection, infiltration or surface agent provided that it lends itself to the preparation of the composition according to the invention and develops its effect once in contact with the tissues. Said anesthetic agent will preferably be chosen from cocaine, procaine, cinchocaine, lidocaine, diperodon, dyclonine, pramocaine or some of their water-soluble salts, in particular their hydrochlorides. As hydrochlorides, mention may in particular be made of the hydrochlorides of cocaine, procaine, tetracaine or lidocaine (Xylocaine registered trademark), the latter being particularly appreciated. La concentration en agent anesthésique local peut varier fortement, en fonction de l'effet recherché et du type de tissu à traiter. Pour le traitement des muqueuses par exemple, la concentration en agent anesthésique sera relativement faible, de l'ordre de 0,5 à 1,5% environ, en poids. Des concentrations de l'ordre de 3 à 12% environ, en poids, conviennent à la plupart des usages, mais on peut aller au-delà, par exemple jusqu'à 25% environ en poids, sans nuire à la stabilité de l'émulsion.The concentration of local anesthetic agent can vary greatly, depending on the desired effect and the type of tissue to be treated. For the treatment of the mucous membranes for example, the concentration of anesthetic agent will be relatively low, of the order of approximately 0.5 to 1.5%, by weight. Concentrations of the order of approximately 3 to 12%, by weight, are suitable for most uses, but it is possible to go beyond this, for example up to approximately 25% by weight, without harming the stability of the emulsion. Pour la préparation- de la composition selon l'invention, on a recours aux techniques usuelles. L'agent anesthésique est en général ajouté sous forme de solution aqueuse, avec les autres constituants hydrosolubles de l'émulsion, aux substances constituant la phase huileuse.For the preparation of the composition according to the invention, recourse is had to the usual techniques. The anesthetic agent is generally added in the form of an aqueous solution, with the other water-soluble constituents of the emulsion, to the substances constituting the oily phase. On obtient ainsi une composition à base d'une émulsion aqueuse de peroxyde d'hydrogène présentant toutes les garanties de stabilité et de stérilité requises pour son emploi. Une telle composition peut se présenter sous forme de pommade plus ou moins consistante ou sous forme d'émulsion relativement liquide. Réservée à un usage externe, elle permet de traiter efficacement des blessures ouvertes comme les ulcères, les troubles consécutifs aux hémorroïdes et en particulier les brûlures.A composition based on an aqueous emulsion of hydrogen peroxide having all the guarantees of stability and sterility required for its use is thus obtained. Such a composition can be in the form of a more or less consistent ointment or in the form of a relatively liquid emulsion. Reserved for external use, it can effectively treat open wounds such as ulcers, disorders resulting from hemorrhoids and in particular burns. Le détail d'une telle composition est donné ci-après, à titre d'exemple non limitatif.The detail of such a composition is given below, by way of non-limiting example. Exemple:Example: On prépare une première composition de type huile, à l'aide des ingrédients suivants:A first composition of the oil type is prepared, using the following ingredients: Vaseline 570,0 gVaseline 570.0g Paraffine liquide 412,5 gLiquid paraffin 412.5 g Alcool cétylique 382,5 gCetyl alcohol 382.5 g Monostéarine 330,0 gMonostearin 330.0 g Total 1695,0 gTotal 1695.0g On effectue séparément le mélange des ingrédients hydrosolubles suivants:The following water-soluble ingredients are mixed separately: H202 à 30% 825 gH202 at 30% 825g «Tween 80» 89 g“Tween 80” 89g Acide salicylique 10 gSalicylic Acid 10g Xylocaine 100% 440 gXylocaine 100% 440g Eau distillée 7941 gDistilled water 7941 g Total 9305 gTotal 9305g La Xylocaine est introduite à 38° C dans le mélange aqueux, sous agitation. Les phases «huile» et «eau» sont ensuite mélangées dans un appareil approprié à 80° C, jusqu'à obtention d'une émulsion homogène. On obtient ainsi 11 kg d'une composition contenant 2% (poids) de peroxyde d'hydrogène et 4% de Xylocaine.The Xylocaine is introduced at 38° C. into the aqueous mixture, with stirring. The “oil” and “water” phases are then mixed in a suitable device at 80° C., until a homogeneous emulsion is obtained. 11 kg of a composition containing 2% (weight) of hydrogen peroxide and 4% of Xylocaine are thus obtained. 55 1010 1515 2020 2525 3030 3535 4040 4545 5050 5555 6060 RR
CH495386A 1986-12-12 1986-12-12 DISINFECTANT COMPOSITION FOR HUMAN OR VETERINARY USE. CH668912A5 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CH495386A CH668912A5 (en) 1986-12-12 1986-12-12 DISINFECTANT COMPOSITION FOR HUMAN OR VETERINARY USE.
DE19873741561 DE3741561A1 (en) 1986-12-12 1987-12-08 DISINFECTING COMPOSITION FOR HUMAN OR VETERINAER APPLICATION
FR8717235A FR2608048A1 (en) 1986-12-12 1987-12-10 DISINFECTANT COMPOSITION FOR HUMAN OR VETERINARY USE
GB08728875A GB2198642A (en) 1986-12-12 1987-12-10 Hydrogen peroxide emulsion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH495386A CH668912A5 (en) 1986-12-12 1986-12-12 DISINFECTANT COMPOSITION FOR HUMAN OR VETERINARY USE.

Publications (1)

Publication Number Publication Date
CH668912A5 true CH668912A5 (en) 1989-02-15

Family

ID=4285394

Family Applications (1)

Application Number Title Priority Date Filing Date
CH495386A CH668912A5 (en) 1986-12-12 1986-12-12 DISINFECTANT COMPOSITION FOR HUMAN OR VETERINARY USE.

Country Status (4)

Country Link
CH (1) CH668912A5 (en)
DE (1) DE3741561A1 (en)
FR (1) FR2608048A1 (en)
GB (1) GB2198642A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ552862A (en) 2005-03-15 2009-03-31 Animal Ethics Pty Ltd A topical analgesic composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3954974A (en) * 1972-06-09 1976-05-04 Paul Herzog Disinfectant for the surface of human body parts containing hydrogen peroxide
GB1539771A (en) * 1976-09-01 1979-02-07 Quinoderm Ltd Dermatological compositions

Also Published As

Publication number Publication date
DE3741561A1 (en) 1988-06-23
FR2608048A1 (en) 1988-06-17
GB2198642A (en) 1988-06-22
GB8728875D0 (en) 1988-01-27

Similar Documents

Publication Publication Date Title
US8343515B2 (en) Perfluorocarbon gel formulations
US6488965B1 (en) Synergistic antimicrobial preparations containing chlorite and hydrogen peroxide
BE891088R (en) COMPOSITION BASED ON BENZOYL PEROXIDE
US20120225102A1 (en) Perfluorocarbon gel formulations
CA2138112A1 (en) Water-in-oil emulsion containing retinol, its use and its conditioning
FR2458285A1 (en) TRANSDERMAL PHARMACEUTICAL PREPARATION WITH ISOSORBID DINITRATE
EP2819666B1 (en) Gelling formulation based on calcium gluconate
CH668912A5 (en) DISINFECTANT COMPOSITION FOR HUMAN OR VETERINARY USE.
EP0434628B1 (en) Composition for cosmetics or pharmaceutical use
FR2571619A1 (en) PHARMACEUTICAL PRODUCT FREE OF GLUCOCORTICOIDS FOR LOCAL TREATMENT OF PSORIASIS
KR102116022B1 (en) Cosmetic composition with microspheres containing high concentration of oxygen and method for producing the same
FR2539991A1 (en) FATTY OINTMENT CONTAINING IN PARTICULAR HYDROCORTISONE BUTYRO-PROPIONATE, PREPARATION METHOD THEREOF AND THERAPEUTIC APPLICATION THEREOF
JP3516952B2 (en) Topical composition for medical use
FR2703601A1 (en) Emulsion of the oil type in water containing milk.
CH670951A5 (en) Cosmetic, cicatrising and disinfectant emulsions - contain vitamin=A ester and hydrogen peroxide
FR2719746A1 (en) Antiseptic and / or disinfecting solution, intended in particular for human and / or animal hygiene, comprising at least hexamidine and an iodophore.
EP0350438B1 (en) Composition for use in cosmetics or pharmacy
EP0463937A1 (en) Lotion for the treatment of alopecia
FR2622800A1 (en) Process for preparing a product for combatting viral complaints, especially cutaneomucosal viral complaints, pharmaceutical compositions and medicaments obtained using this process
BE1000153A4 (en) Anti-acne STABLE COMPOSITION BASED ERYTHROMYCIN.
FR2707497A1 (en) Pharmaceutical composition for the treatment of chronic skin ulcers.
RU2112548C1 (en) Preparation for suppurative wound treatment at diabetes mellitus background
FR2498932A1 (en) COMPOSITION CONTAINING LECITHIN AND OXYGENATED WATER AND USE THEREOF IN THE TREATMENT OF ACNE
FR2808690A3 (en) Medicinal formulation used for relief of muscle tension contains local anaesthetic, dwarf pine oil, camphor, horse chestnut extract and ethereal oil in water and alcohol carrier
BR102018075157A2 (en) PHARMACEUTICAL COMPOSITION COMPOSING SILVER SULFADIAZINE AND COLAGENASE IN THE FORM OF A DERMATOLOGICAL CREAM FOR THE TREATMENT OF WOUNDS AND BURNS AND THEIR RESPECTIVE PROCESS OF OBTAINING

Legal Events

Date Code Title Description
PL Patent ceased